News
-
NEW PUBLICATION | Guidelines for the Management of Non-Transfusion-Dependent β-Thalassaemia
This novel edition is an invaluable contribution in upgrading the care of individuals with NTDT, a condition that has been underestimated in importance and clinical significance for many years. TIF…
Read More » -
-
G6PD | Common Enzyme Deficiency Linked with COVID Severity
In Black men under 65, for example, those with the common enzyme deficiency had a roughly 1.5-fold higher risk for severe illness (OR 1.47, 95% CI 1.03-2.09), reported Lavannya Pandit,…
Read More » -
TIF’s Executive Director Chosen Among ‘Women Who Advance Associations 2023′
‘Women Who Advance Associations’ celebrates the great talent of the international association community. For International Women’s Day, marked annually on March 8, they showcase female trailblazers and change-makers who champion…
Read More » -
INTERNATIONAL THALASSAEMIA DAY 2023 | The Official Page Is Now Live!
Head to the official webpage https://thalassaemia.org.cy/itd2023/ to explore the fantastic International Thalassaemia Day resources and activities, learn more about the ‘Be Aware. Share. Care.’ theme and how to improve…
Read More » -
NEW REVIEW | Treatment Landscape of Rare Anaemias Is Shifting Rapidly
Writing in Frontiers in Medicine, the authors began by reviewing congenital and acquired forms of anaemia. Those include sickle cell disease (SCD) and hemolytic anemias (CHAs), both congenital, and autoimmune hemolytic…
Read More » -
TOP STORY | EU Approves Luspatercept for Anemia in Patients with Non–Transfusion-Dependent β-Thalassaemia
The approval was based on findings from the phase 2 BEYOND trial, which demonstrated that 77.1% of patients treated with luspatercept (n = 74/96) experienced a mean haemoglobin (Hb) increase…
Read More » -
EMERGENCY APPEAL | TIF Rallies to Provide Earthquake Relief in Turkey and Syria
Among these people, the Thalassaemia International Federation (TIF) estimates that at least 2,000 patients with thalassaemia have been affected, 70% of whom are children and adolescents under the age of…
Read More » -
TIF2023 | The Top International Conference On Thalassaemia Returns This November
The Conference, jointly organised by TIF, the Malaysian Haematology Society, and the Federation of Malaysia Thalassaemia Societies, will feature two parallel programmes – a Scientific Programme for Healthcare Professionals and…
Read More » -
SICKLE CELL DISEASE | Hydroxyurea Use Linked To Higher Rates Of Spleen Removal
The study’s findings also indicated that SCD children treated with hydroxyurea underwent splenectomy surgery at a significantly younger age compared with those not given the oral medication. That result came…
Read More »